To evaluate the colonization of Candida species and the importance of cross-contamination with Candida albicans, we prospectively screened clinical specimens obtained from surgical patients in the intensive care unit (ICU) who had a high risk of yeast colonization. Genotyping of C. albicans was performed using microsatellite markers. Thirty-six of 94 patients acquired nosocomial yeast colonization and/or infection. A total of 1126 specimens were cultured, 167 (15%) of which yielded yeasts. All 122 isolates of C. albicans recovered from the 30 C. albicans-positive patients were genotyped. Twenty-four different genotypes were identified. No genotype was systematically associated with a specific room or time. Isolates recovered from different body sites of patients at different times had identical genotypes. Acquisition of C. albicans in the surgical ICU seems to be mainly endogenous. Microsatellite markers should also be developed for typing non-albicans Candida species to learn whether their epidemiology differs from that of C. albicans.
Of the yeasts that have emerged as major fungal pathogens in recent years, Candida albicans is the most prevalent in surgical intensive care units [1] . In abdominal surgery units, some patients have a high risk of Candida colonization, infection, or both. These populations include patients with gastrointestinal perforations or anastomotic leakages, liver transplant recipients, and patients with acute pancreatitis [2] [3] [4] . The route of acquisition is of interest to determine the risk of nosocomial transmission of C. albicans and, as a consequence, to implement appropriate preventive measures for patients with prolonged stays in surgical intensive care units (ICUs).
The genetic relationship between clinical isolates can be studied using genetic fingerprinting with DNA-based methods [5] . We have recently developed an analysis of 3 microsatellites markers defined as tandemly repetitive stretches of 2-5 nucleotides [6] . The polymorphism of the microsatellite markers is analyzed after amplification of specific loci by use of fluorescent primers and migration in a high-resolution gel. Reliability is achieved by an automated procedure-that is, an automatic sequencer is used to measure the length of the alleles. The data may be computerized, and the throughput of the technique is high. The discriminatory power of the technique is very close to 1 (0.97), and the markers are stable over many generations. Therefore, the microsatellite marker typing system fulfills several of the biological and technical criteria, such as high polymorphism, reproducibility, and feasibility, that denote reliability for use in epidemiological studies [7] .
To evaluate the frequency of yeast colonization and/or infection and the routes of colonization, we therefore prospectively screened clinical samples obtained from selected patients in our surgical unit who had undergone abdominal surgery. All C. albicans isolates recovered from these patients were genotyped simultaneously.
PATIENTS AND METHODS

Patients.
The study was conducted from 1 November 1999 through 30 October 2000 in a 16-bed surgical ICU that received patients who had undergone major abdominal intervention or who had major comorbidities. This observational study did not need approval from the Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale, because it did not modify current diagnostic or therapeutic strategies. Written or oral informed consent was obtained from patients or from their relatives. The study was focused on patients with a known high risk of having been colonized or infected with Candida species [2, 4] . Patients у18 years of age were eligible for the study if they met 1 of the following criteria: (1) recent abdominal surgery and an expected stay in an ICU for у7 days, (2) gastrointestinal perforations or anastomotic leakages that were either suspected or confirmed by surgery, (3) liver transplantation, or (4) acute pancreatitis. All patients had indwelling urinary bladder catheters, and most received an orally administered amphotericin B suspension, 1500 mg/day. Data collection. Clinical data were collected prospectively for each patient. The following information was recorded: severity of illness, as measured by the new Simplified Acute Physiology Score (SAPS II) [8] ; age; sex; type of surgery; severity of underlying medical conditions at the time of admission, stratified according to the criteria of McCabe and Jackson [9] as likely to be fatal, ultimately fatal, or nonfatal; need for and duration of mechanical ventilation; presence of monitoring equipment (i.e., arterial catheter and central venous catheter); receipt of antibiotic therapy during a stay in the ICU (receipt of a single dose of 1 antibiotic was not taken into account); and transfusion requirement. Obesity was defined as a body mass index of 130, for men, or 128.6, for women. A history of a recent (within 3 months) loss of у10% of body weight signified substantial protein-calorie malnutrition. Immune deficiency was considered when patients had metastatic cancer, hematologic malignancy, or AIDS, according to the definitions of Le Gall et al. [8] , or when patients received immunosuppressive drugs (cyclosporine, tacrolimus, or corticosteroids).
Microbiological investigations. As much as possible, specimens for culture were obtained from the blood, intra-abdominal specimens (peritoneal fluid, bile, and abscess), respiratory tract (tracheal aspirates, bronchoalveolar lavage fluids, and plugged telescopic catheter aspirates), gastric secretions, and urine of all patients at the time of their arrival in the ICU, when clinically indicated, or when surgically available. In addition, as part of routine surveillance, urine, stools, skin and soft tissue (a swab specimen or an aspirate from a surgical wound), and drain effluents were obtained at the time that the patient arrived in the ICU and then weekly thereafter. The specimens were cultured on the chromogenic medium Candida ID (BioMérieux) at 37ЊC for 48 h. This medium is intended to rapidly identify C. albicans [10] and to detect mixtures of different Candida species. All the blue colonies were identified as C. albicans, and the white colonies were phenotyped using the commercial ATB ID 32C (API; BioMérieux) and micromorphological analysis on rice-extract agar (Becton Dickinson).
Patients with "ICU-acquired Candida species" were defined as patients who were newly colonized and/or infected with Candida species after having been hospitalized in the ICU for a minimum of 72 h [11] . Colonization was defined by у1 positive result of yeast cultures performed using specimens obtained from any body site, regardless of the count of colonyforming units. For study purposes only, patients were considered to have a Candida infection if they had intra-abdominal abscesses or peritonitis caused by Candida species, candidemia (у1 blood culture positive for Candida species), or Candida urinary tract infections (1 colonies of Candida species per 5 10 milliliter of urine with pyuria in a symptomatic patient). Candida organisms isolated from any sterile area, including specimens with concurrent bacterial isolates, were considered to be pathogens.
Genotyping of C. albicans by analysis of microsatellite markers. Amplifications were directly performed on a single C. albicans colony clearly isolated on the Candida ID plates, as described elsewhere [6] . Three loci, located on 3 different chromosomes of C. albicans, were tested and were subsequently referred to as "EF3," "CDC3," and "HIS3," having been named after the genes to which they are close. Primers were designed to amplify the microsatellite markers, and 1 primer of each set was 5 -labeled with different dyes. PCR products were run on a 36-cm-long acrylamide urea gel along with an internal standard. Signals were read using a 377 automatic sequencer (Applied Biosystems), and the data were stored and analyzed with the 372 Genescan software (Applied Biosystems). To ensure reproducibility of the results, a reference strain was systematically run as a control in each gel.
For each marker and for a given isolate, 1-2 bands were observed because C. albicans is diploid and because each marker tests a single locus. Each band observed was assigned to an allele. Therefore, each isolate was characterized by a profile of 6 alleles. The results were expressed as the name of the locus tested and the length of the 2 alleles observed in base pairs. For instance, the results for a given isolate were CDC3 (117-125), EF3 (126-135), and HIS3 (150-150). Some isolates can be heterozygous for one locus and homozygous for another. To simplify, a letter (from "A" to "X") was arbitrarily attributed to a given allele association.
Statistical analysis. Data were computerized and analyzed by use of Stat-View 5.0 statistical packages (SAS Institute). We expressed continuous variables as the mean (‫ע‬SD) or as the median and 25th-75th percentiles if their distribution was skewed. x 2 tests were used to compare proportions and rates. The Mann-Whitney U test was used to analyze continuous variables that were not normally distributed; 2-tailed t tests were used to compare normally distributed variables. Multivariate modeling in the form of Cox proportional hazard analysis was used to evaluate potential risk factors for acquisition of Candida species in the ICU. In the univariate analysis, those variables associated with the acquisition of Candida colonization and/or infection in the ICU and for which were P ! .1 entered into the model. Hazard ratios (HRs) and 95% CIs were calculated for all significant predictors. Statistical significance was defined as . P р .05
RESULTS
Patient characteristics.
During the study period, 303 patients were admitted to the ICU either to receive treatment for acute pancreatitis or after undergoing abdominal surgery, and 209 of them were not included in the study (169 were not included because their length of stay in the ICU was !7 days; 29, because of logistical problems; and 11, because the attending physician did not enroll them in the study). The clinical characteristics of the excluded patients were as follows: mean age (‫ע‬SD), 59 ‫ע‬ 18 years; mean SAPS II score (‫ע‬SD), 21 ‫ע‬ 13 points; median length of stay in the ICU, 5 days (25th-75th percentiles, 3-8 days); and death (7 patients [3.3%]).
A total of 94 patients were included in the study. Patients were sampled for fungi a median of 2 times (25th-75th percentiles, 1-4 times), and a median of 8 specimens (25th-75th percentiles, 5-15 specimens) were obtained per patient. Figure  1 illustrates the number of patients hospitalized in the ICU each week and the number of patients from whom cultures were performed. Of the 43 patients (46%) who were found to be positive for Candida, 7 (7.4%) were positive at the time of entry into the study, and 36 patients (38.3%) had new acquisition of Candida species on у1 occasion after having been hospitalized in the ICU for 72 h. Forty-two percent of these patients (15 of 36) acquired Candida species beyond the first week after their admission to the ICU ( figure 1) Sixteen patients were considered to be infected. Six of these patients were already infected at the time of admission to the ICU. Ten patients (10.6%) acquired nosocomial Candida infection after a median stay of 16 days (25th-75th percentiles, 9-23 days) in the ICU (4 patients had peritonitis or intra- Microbiological investigation. A total of 1126 specimens were examined, 167 (15%) of which grew yeasts in culture (table 2). The 3 most common sites from which culture-positive specimens were obtained were the digestive tract (40.0%), the skin and soft tissues (32.0%), and the respiratory tract (25.5%). Forty-three patients had у1 positive specimen. C. albicans was isolated in 30 patients (alone in 21 patients and in association with other Candida species in 9 patients). The Candida species most frequently recovered were C. albicans (from 56.0% of patients) and C. glabrata (from 19.0% of patients). Other Candida species that were recovered less frequently included C. parapsilosis and C. tropicalis (from 7.0% of patients each) and C. krusei, C. kefyr, C. lypolytica, C. guillermondi, and C. sake (from 2.0% of patients each). Only 1 species was recovered from 86.0% of Candida-positive patients. For the 30 patients colonized by and/or infected with C. albicans, either alone or in association with other Candida species, analysis of microsatellite markers yielded 24 profiles (profiles A-X; figure 2) for 112 isolates tested. Compared with our previous findings, we did not find new alleles among the isolates tested, but we identified 5 new allele associations [6] . The strains isolated from different body sites (superficial and deep sites) of the same patient at different times had identical profiles. When infection occurred, the genotype was identical, confirming that the patient was well infected with his or her own colonizing strain.
The chronological and geographical distribution of the different profiles is reported in figure 2 . Three genotypes were detected in 2-4 patients, none of whom shared a room. Profile I, encountered in 4 patients (13%), was also the profile most frequently encountered among 100 unrelated isolates (17%) [6] . The remaining 21 profiles were each only detected in a single patient.
DISCUSSION
Our results showed that 38.3% (36 of 94) of highly selected at-risk surgical patients had been colonized by or infected with Candida organisms during their stay in the ICU. We also found that cross-contamination with C. albicans was unlikely in most of the colonized or infected patients.
Frequency of Candida colonization has been reported to range from 18.0% [12, 13] to 44.0% [14] in surgical patients. When the focus has been on specific groups of patients, higher percentages have been noted [15] [16] [17] , reaching 90.0% in one study [3] . Sixty percent of our Candida-positive patients were colonized during the first week; 10%-20% were subsequently colonized each week, a figure not dissimilar to that found in previous studies [16] . Colonized patients tended to be older, but older age was not identified as a risk factor, although frequency and intensity of carriage of Candida species increased with age [18] . Previous antibiotic therapy, reoperation, and total parenteral nutrition were the 3 risk factors for colonization that were identified, confirming the findings of studies published elsewhere [4, 19, 20] . In this population, antifungal prophylaxis with oral amphotericin B seemed ineffective in preventing colonization or infection with Candida species.
In our study, only 15.0% of clinical specimens grew Candida species, compared with 42.0% of such specimens obtained from surgical patients with intra-abdominal perforations [3] . It is noteworthy that all the samples obtained from a given patient for culture were not consistently positive for yeast once a patient was positive in our study, as in a study published elsewhere [16] . The main deleterious consequence for a microbiological study is that some specimens can be alternatively positive or negative, depending on the seeding of the culture media. The role of antifungal drugs and the overgrowth of some bacteria in inhibiting growth on cultures have to be considered to explain false-negative results for fungi. Therefore, quantification of the yeast count probably has little meaning for decisionmaking in these patients. Use of density of colonization and, as a consequence, the number of anatomical sites to be sampled are still matters of controversy [3, 21] . Nevertheless, we think that clinical samples from body sites that could be the source of potential infectious complications, such as intra-abdominal secretions [2, 13, 22] , should at least be obtained from patients without clinical improvement [19] .
In our study, C. albicans remained the most prevalent species recovered (from 56% of patients), with C. glabrata the second most prevalent species (from 19.0% of patients), as reported elsewhere [1, 3, 23] , justifying our choice to focus on C. albicans in a first step. The frequency of each genotype was not significantly different from that obtained from 100 unrelated isolates, including reference strains [6] . The fact that some genotypes were more frequent than others and that no allele was associated with a specific anatomical site or any pathogenic effect had already been observed in a completely different hospital by use Results of the genotyping of Candida albicans isolates from 30 patients in the surgical intensive care unit (ICU) who were colonized by or infected with C. albicans. Numbers 9-24 denote patient rooms, which were divided into 4 blocks (B1-B4). The blocks alternately closed during the study period. Sinks were located inside every block, and individual bottles that contained an alcohol-based preparation of 0.5% chlorhexidine gluconate were available in every room. For each patient, the genotype determined by the microsatellite markers is denoted by a letter of the alphabet ("A"-"X"). Some patients moved from one room to another during the study. Pt, patient; ⅷ, length of stay in the ICU; *identified infected patients.
of the same fingerprinting method [24] . Although exogenous acquisition of Candida organisms is possible [11] , and although Candida organisms may be transmitted via the hands of health care workers [1, 9, 16] , in the present study, the majority of C. albicans infections appeared to originate from an endogenous source.
Evidence of an endogenous source of yeast infection relies on several arguments. First, at a given anatomical site, colonization with the same C. albicans strain persisted in all the patients, confirming the findings of previously published studies [16, 25] . Second, colonization frequently preceded infection [21, 26] , and the colonizing and infecting strains had identical genotypes [11, 25, 27, 28] . Third, at a given time, a single patient's strain was isolated from multiple anatomical sites [27, 28] . Fourth, the overgrowth of yeast generally results from alterations in host defenses, as is observed after prolonged antibacterial therapy, which was confirmed to be a risk factor in our study. Finally, the analysis of the genotype repartition did not support nosocomial transmission. No genotype was systematically associated with a specific room or a specific time. We cannot exclude the possibility that patients who stayed in the surgical ward for !7 days would have been the source of nosocomial transmission. However, in our experience, these patients have negative culture results.
In conclusion, our results strongly suggest that C. albicans acquisition is mainly, perhaps only, endogenous. Therefore, in the ICU, efforts must be focused on endogenous acquisition, assuming that the current measures for preventing cross-transmission of microorganisms are correctly followed [29] . This can be based on regular screening of high-risk patients, as has been suggested previously [21] , to implement preemptive strategies already followed elsewhere [15, 30] . The microsatellite markers should be also developed for typing other medically important yeasts, such as C. glabrata and C. parapsilosis. The emergence of non-albicans Candida species has been attributed to the increasing use of azole drugs [31] , and the spread of these species can be different from that of C. albicans.
